| Característica |
Objectiu de la convocatòria
This program supports pre-clinical and clinical research in the field of solid tumor oncology in Australia, Canada, and Europe. For the 2026 cycle, the award will focus on breast, endometrial, upper gastrointestinal (esophageal, gastric, and gastroesophageal junction), and lung cancer.
|
Característiques principals
Areas of research may include, but are not limited to:
Disparities and inequities in cancer care
Agnostic approaches to target solid tumors
Combinational drug strategies/approaches to treatment
Resistance mechanism identification/novel approaches to addressing resistance mechanisms
Transformative, therapeutic modalities/approaches to treatment
Patient-specific factors that are predictors of toxicity, genomic polymorphisms and impact treatment response
Novel targets and/or biomarkers/imaging techniques, and novel diagnostic, prevention, and treatment strategies
Research to improve Quality of Life (QoL) Patient-Reported Outcomes (PRO's) e.g adverse events, addressing unmet needs for patients
Any other pre-clinical or clinical research that addresses an unmet medical need or gap in scientific knowledge
|
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact:
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: [email protected] Ext.: 1670
Marta López: [email protected] Ext.: 1576
|
Convocatòria (URL)
https://researchscholars.gilead.com/solid_tumors_ace/about
|
Requisits
Applicants must meet the following requirements:
Hold an MD or PhD (equivalent degree) at time of award. MD qualifications would have to have been obtained within the last 10 years and PhD qualifications would have to have been obtained within the last 5 years
Early to Mid-career scientists with a strong research track record who hold a position at a recognised research institution in one of the eligible countries at the time of application (see below for list of countries) and whose tenure of that position encompasses the projected period of the award from the Gilead and Kite scholarship program
Have a strong career interest in Oncology Solid Tumors
Have a research mentor with extensive experience in the field of Oncology Solid Tumors.
Be able to devote at least 30% of professional time to research for the next two years (versus administrative, patient care, or teaching responsibilities)
Be able to complete the proposed research within the two-year award period, providing evidence (manuscript, presentation, or abstracts) resulting from the research
Exceptions to the above can apply, for example, having taken time out for parental leave or family bereavement
The Research Scholars Program in Oncology Solid Tumors. is open to emerging investigators from countries with the following regions and countries: Europe (all countries), Canada or Australia
Award selections are made without discrimination based on race, ethnicity, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression.
|
Dotació
$90,000 per year
|
Durada
2 years
|
Documentació
Applicants must complete the online application form and include the following materials:
Research abstract
Research proposal
Bibliography of relevant references
Applicant's biosketch, inclusive of publications, if applicable
Mentor's biosketch and co-mentor(s) biosketch, if applicable
Letter of support from the mentor which includes
Letter of collaboration (only required if you have co-mentorship)
Detailed budget and completed budget summary
Current or pending applications for funding
Letter of support from the department chair or division chief that documents the institution is willing and has the ability to commit the resources necessary for the applicant to complete the proposed research, including sufficient protected time
|